ER expression is related to patient age and correlates with lower tumour grade and proliferation, less aneuploidy, less frequent amplification of the c-erbB2 (HER2) oncogene and progesterone receptor (PR) expression [2]. This evidence concerns the gene PGR and neoplasm.